{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:58:10Z","timestamp":1792789090870,"version":"4.5.0"},"reference-count":56,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Little Green Pharma Pty Ltd."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Cannabinoids are emerging as promising treatments for inflammatory diseases such as ulcerative colitis. Specifically, cannabinoid 2 (CB2) receptors, which are upregulated during inflammation, have been distinctively linked to anti-inflammatory and analgesic effects. HU308, a synthetic cannabinoid developed to activate CB2 receptors selectively, aims to minimize unwanted off-target side effects. This study evaluated the effectiveness of both cannabidiol (CBD) and HU308 in mouse models of dextran sodium sulphate (DSS)-induced colitis, which mimic the acute and chronic phases of ulcerative colitis. Mice were treated with DSS in drinking water (four percent for the acute model and one to two percent for the chronic model) to induce colitis, as indicated by increased disease activity index (DAI) scores and inflammatory markers. Treatment with 60 mg\/kg of CBD, but not lower doses, significantly reduced colitis symptoms, such as inflammation, cytokine levels, and MPO activity, while also normalizing glucagon-like peptide-1 (GLP-1) levels. HU308 showed comparable efficacy to high-dose CBD (60 mg\/kg) but at a much lower dose (2.5 mg\/kg), without observable toxicity. HU308 effectively normalized DAI scores, colon inflammation, ammonia levels, and GLP-1 expression in both colitis models. These results suggest that both CBD and HU308 are promising treatments for ulcerative colitis. However, HU308 demonstrates enhanced therapeutic potential by achieving similar outcomes at a fraction of the dose required for CBD, reducing the risk of off-target side effects. The ability of HU308 to modulate GLP-1, a biomarker of gut endocrine function, further underscores its promise as a novel treatment option.<\/jats:p>","DOI":"10.3390\/cells13232013","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T11:27:53Z","timestamp":1733398073000},"page":"2013","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Comprehensive Assessment of Cannabidiol and HU308 in Acute and Chronic Colitis Models: Efficacy, Safety, and Mechanistic Innovations"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5430-825X","authenticated-orcid":false,"given":"Dinesh","family":"Thapa","sequence":"first","affiliation":[{"name":"Curtin Health Innovation Research Institute (CHIRI), Curtin University, Perth, WA 6102, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan","family":"Patil","sequence":"additional","affiliation":[{"name":"Curtin Health Innovation Research Institute (CHIRI), Curtin University, Perth, WA 6102, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon N","family":"Warne","sequence":"additional","affiliation":[{"name":"Curtin Health Innovation Research Institute (CHIRI), Curtin University, Perth, WA 6102, Australia"},{"name":"College of Science, Health, Engineering and Education, Murdoch University, Perth, WA 6150, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0038-7391","authenticated-orcid":false,"given":"Rodrigo","family":"Carlessi","sequence":"additional","affiliation":[{"name":"Curtin Health Innovation Research Institute (CHIRI), Curtin University, Perth, WA 6102, Australia"},{"name":"Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Nedlands, WA 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9801-7235","authenticated-orcid":false,"given":"Marco","family":"Falasca","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"ref_1","first-page":"33","article-title":"Inflammatory Bowel Disease: An Expanding Global Health Problem","volume":"6","year":"2013","journal-title":"Clin. Med. Insights Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/gutjnl-2020-322129","article-title":"Emerging Treatment Options for Extraintestinal Manifestations in IBD","volume":"70","author":"Greuter","year":"2021","journal-title":"Gut"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","article-title":"Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management","volume":"161","author":"Rogler","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Cai, Z., Wang, S., and Li, J. (2021). Treatment of Inflammatory Bowel Disease: A Comprehensive Review. Front. Med., 8.","DOI":"10.3389\/fmed.2021.765474"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Al-Bawardy, B., Shivashankar, R., and Proctor, D.D. (2021). Novel and Emerging Therapies for Inflammatory Bowel Disease. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.651415"},{"key":"ref_6","first-page":"453","article-title":"Novel Therapies for Patients with Inflammatory Bowel Disease","volume":"18","author":"Santiago","year":"2022","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/can.2017.0041","article-title":"The Cannabinoids Delta(8)THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation","volume":"3","author":"Thapa","year":"2018","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Thapa, D., Cairns, E.A., Szczesniak, A.-M., Kulkarni, P.M., Straiker, A.J., Thakur, G.A., and Kelly, M.E.M. (2020). Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation. Molecules, 25.","DOI":"10.3390\/molecules25020417"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Thapa, D., Warne, L.N., and Falasca, M. (2023). Pharmacohistory of Cannabis Use-A New Possibility in Future Drug Development for Gastrointestinal Diseases. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241914677"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/ptr.4781","article-title":"Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview: CBD AND IBD","volume":"27","author":"Esposito","year":"2013","journal-title":"Phytother. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3233\/CH-168021","article-title":"Experimental Cannabidiol Treatment Reduces Early Pancreatic Inflammation in Type 1 Diabetes","volume":"64","author":"Lehmann","year":"2017","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Castillo-Arellano, J., Canseco-Alba, A., Cutler, S.J., and Le\u00f3n, F. (2023). The Polypharmacological Effects of Cannabidiol. Molecules, 28.","DOI":"10.3390\/molecules28073271"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"106025","DOI":"10.1016\/j.phrs.2021.106025","article-title":"Modulatory Role of the Endocannabinoidome in the Pathophysiology of the Gastrointestinal Tract","volume":"175","author":"Lian","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41390-022-02109-5","article-title":"Increased Expression of CB2 Receptor in the Intestinal Biopsies of Children with Inflammatory Bowel Disease","volume":"93","author":"Strisciuglio","year":"2023","journal-title":"Pediatr. Res."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Marqu\u00e9z, L., Su\u00e1rez, J., Iglesias, M., Bermudez-Silva, F.J., Rodr\u00edguez de Fonseca, F., and Andreu, M. (2009). Ulcerative Colitis Induces Changes on the Expression of the Endocannabinoid System in the Human Colonic Tissue. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006893"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00213-020-05712-8","article-title":"Cannabidiol: Pharmacology and Therapeutic Targets","volume":"238","author":"Britch","year":"2021","journal-title":"Psychopharmacology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"14228","DOI":"10.1073\/pnas.96.25.14228","article-title":"HU-308: A Specific Agonist for CB(2), a Peripheral Cannabinoid Receptor","volume":"96","author":"Hanus","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2174\/1381612003399509","article-title":"Looking Back at Cannabis Research","volume":"6","author":"Mechoulam","year":"2000","journal-title":"Curr. Pharm. Des."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuropharm.2016.08.030","article-title":"Cannabinoid 2 Receptor Is a Novel Anti-Inflammatory Target in Experimental Proliferative Vitreoretinopathy","volume":"113 Pt B","author":"Szczesniak","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Hall, S., Faridi, S., Trivedi, P., Sultana, S., Ray, B., Myers, T., Euodia, I., Vlatten, D., Castonguay, M., and Zhou, J. (2022). Selective CB2 Receptor Agonist, HU-308, Reduces Systemic Inflammation in Endotoxin Model of Pneumonia-Induced Acute Lung Injury. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232415857"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Berger, G., Arora, N., Burkovskiy, I., Xia, Y., Chinnadurai, A., Westhofen, R., Hagn, G., Cox, A., Kelly, M., and Zhou, J. (2019). Experimental Cannabinoid 2 Receptor Activation by Phyto-Derived and Synthetic Cannabinoid Ligands in LPS-Induced Interstitial Cystitis in Mice. Molecules, 24.","DOI":"10.3390\/molecules24234239"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/0023677217742681","article-title":"A Refined and Translationally Relevant Model of Chronic DSS Colitis in BALB\/c Mice","volume":"52","author":"Hoffmann","year":"2018","journal-title":"Lab. Anim."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nmeth.1455","article-title":"Coding of Facial Expressions of Pain in the Laboratory Mouse","volume":"7","author":"Langford","year":"2010","journal-title":"Nat. Methods"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/MIB.0b013e3182802c7c","article-title":"Colonoscopy and \u00b5PET\/CT Are Valid Techniques to Monitor Inflammation in the Adoptive Transfer Colitis Model in Mice","volume":"19","author":"Heylen","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12950-016-0129-0","article-title":"Abnormal Cannabidiol Attenuates Experimental Colitis in Mice, Promotes Wound Healing and Inhibits Neutrophil Recruitment","volume":"13","author":"Krohn","year":"2016","journal-title":"J. Inflamm."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/ibd.20787","article-title":"Therapeutic Potential of Helminth Soluble Proteins in TNBS-Induced Colitis in Mice","volume":"15","author":"Ruyssers","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_27","first-page":"4557","article-title":"A Guide to Histomorphological Evaluation of Intestinal Inflammation in Mouse Models","volume":"7","author":"Erben","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/ecco-jcc\/jjy035","article-title":"Development of Reliable, Valid and Responsive Scoring Systems for Endoscopy and Histology in Animal Models for Inflammatory Bowel Disease","volume":"12","author":"Koelink","year":"2018","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Laroui, H., Ingersoll, S.A., Liu, H.C., Baker, M.T., Ayyadurai, S., Charania, M.A., Laroui, F., Yan, Y., Sitaraman, S.V., and Merlin, D. (2012). Dextran Sodium Sulfate (DSS) Induces Colitis in Mice by Forming Nano-Lipocomplexes with Medium-Chain-Length Fatty Acids in the Colon. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0032084"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/nprot.2017.044","article-title":"Chemically Induced Mouse Models of Acute and Chronic Intestinal Inflammation","volume":"12","author":"Wirtz","year":"2017","journal-title":"Nat. Protoc."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3094642","DOI":"10.1155\/2016\/3094642","article-title":"Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control","volume":"2016","author":"Lee","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S2468-1253(18)30159-6","article-title":"Differential Diagnosis of Inflammatory Bowel Disease: Imitations and Complications","volume":"3","author":"Gecse","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.celrep.2017.10.008","article-title":"Enteroendocrine L Cells Sense LPS after Gut Barrier Injury to Enhance GLP-1 Secretion","volume":"21","author":"Lebrun","year":"2017","journal-title":"Cell Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00210-019-01698-z","article-title":"Role of Glucagon-like Peptides in Inflammatory Bowel Diseases\u2014Current Knowledge and Future Perspectives","volume":"392","author":"Zatorski","year":"2019","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Mehdi, S.F., Pusapati, S., Anwar, M.S., Lohana, D., Kumar, P., Nandula, S.A., Nawaz, F.K., Tracey, K., Yang, H., and LeRoith, D. (2023). Glucagon-like Peptide-1: A Multi-Faceted Anti-Inflammatory Agent. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1148209"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"8044","DOI":"10.18632\/aging.204953","article-title":"The Alleviating Effect and Mechanism of GLP-1 on Ulcerative Colitis","volume":"15","author":"Wang","year":"2023","journal-title":"Aging"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"20420188231222367","DOI":"10.1177\/20420188231222367","article-title":"Anti-Inflammatory Role of Glucagon-like Peptide 1 Receptor Agonists and Its Clinical Implications","volume":"15","author":"Alharbi","year":"2024","journal-title":"Ther. Adv. Endocrinol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cmet.2023.11.009","article-title":"Central Glucagon-like Peptide 1 Receptor Activation Inhibits Toll-like Receptor Agonist-Induced Inflammation","volume":"36","author":"Wong","year":"2024","journal-title":"Cell Metab."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Biagioli, M., Marchian\u00f2, S., Roselli, R., Di Giorgio, C., Bellini, R., Bordoni, M., Distrutti, E., Catalanotti, B., Zampella, A., and Graziosi, L. (2022). GLP-1 Mediates Regulation of Colonic ACE2 Expression by the Bile Acid Receptor GPBAR1 in Inflammation. Cells, 11.","DOI":"10.3390\/cells11071187"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.3748\/wjg.14.4280","article-title":"Role of Cytokines in Inflammatory Bowel Disease","volume":"14","year":"2008","journal-title":"WJG"},{"key":"ref_41","first-page":"3678","article-title":"Investigating Intestinal Inflammation in DSS-Induced Model of IBD","volume":"60","author":"Kim","year":"2012","journal-title":"JoVE"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Ke, P., Shao, B.-Z., Xu, Z.-Q., Wei, W., Han, B.-Z., Chen, X.-W., Su, D.-F., and Liu, C. (2016). Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in Macrophages. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0155076"},{"key":"ref_43","first-page":"668","article-title":"Therapeutic Use of Cannabis in Inflammatory Bowel Disease","volume":"12","author":"Ahmed","year":"2016","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.3748\/wjg.v20.i12.3208","article-title":"Interleukin and Interleukin Receptor Gene Polymorphisms in Inflammatory Bowel Diseases Susceptibility","volume":"20","author":"Magyari","year":"2014","journal-title":"WJG"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ibd.20339","article-title":"Role of the Novel Th17 Cytokine IL-17F in Inflammatory Bowel Disease (IBD): Upregulated Colonic IL-17F Expression in Active Crohn\u02bcs Disease and Analysis of the IL17F p.His161Arg Polymorphism in IBD","volume":"14","author":"Seiderer","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/bph.12545","article-title":"Anti-Inflammatory Effects of Cannabinoid CB(2) Receptor Activation in Endotoxin-Induced Uveitis","volume":"171","author":"Toguri","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3233\/CH-151996","article-title":"Cannabinoid 2 Receptor Activation Reduces Leukocyte Adhesion and Improves Capillary Perfusion in the Iridial Microvasculature during Systemic Inflammation","volume":"61","author":"Toguri","year":"2015","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"110771","DOI":"10.1016\/j.intimp.2023.110771","article-title":"Cannabinoid Receptor 2 Alleviates Sepsis-Associated Acute Lung Injury by Modulating Maturation of Dendritic Cells","volume":"123","author":"Zhao","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Wu, A., Hu, P., Lin, J., Xia, W., and Zhang, R. (2018). Activating Cannabinoid Receptor 2 Protects Against Diabetic Cardiomyopathy Through Autophagy Induction. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.01292"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1189\/jlb.0307180","article-title":"Pivotal Advance: Cannabinoid-2 Receptor Agonist HU-308 Protects against Hepatic Ischemia\/Reperfusion Injury by Attenuating Oxidative Stress, Inflammatory Response, and Apoptosis","volume":"82","author":"Rajesh","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.freeradbiomed.2011.02.021","article-title":"Cannabidiol Protects against Hepatic Ischemia\/Reperfusion Injury by Attenuating Inflammatory Signaling and Response, Oxidative\/Nitrative Stress, and Cell Death","volume":"50","author":"Mukhopadhyay","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"101361","DOI":"10.1016\/j.jceh.2024.101361","article-title":"The Story of Ammonia in Liver Disease: An Unraveling Continuum","volume":"14","author":"Anand","year":"2024","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"797862","DOI":"10.1155\/2015\/797862","article-title":"Elevated Blood Ammonia Level Is a Potential Biological Risk Factor of Behavioral Disorders in Prisoners","volume":"2015","author":"Duan","year":"2015","journal-title":"Behav. Neurol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Jin, Y.Y., Singh, P., Chung, H.-J., and Hong, S.-T. (2018). Blood Ammonia as a Possible Etiological Agent for Alzheimer\u2019s Disease. Nutrients, 10.","DOI":"10.3390\/nu10050564"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Adlimoghaddam, A., Sabbir, M.G., and Albensi, B.C. (2016). Ammonia as a Potential Neurotoxic Factor in Alzheimer\u2019s Disease. Front. Mol. Neurosci., 9.","DOI":"10.3389\/fnmol.2016.00057"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1038\/s41467-024-47897-y","article-title":"Metabolic Phenotyping Reveals an Emerging Role of Ammonia Abnormality in Alzheimer\u2019s Disease","volume":"15","author":"Chen","year":"2024","journal-title":"Nat. Commun."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/23\/2013\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:48:01Z","timestamp":1760114881000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/23\/2013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":56,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["cells13232013"],"URL":"https:\/\/doi.org\/10.3390\/cells13232013","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]}}}